Lenalidomide as Immune Adjuvant in Patient's With Chronic Lymphocytic Leukemia (CLL)
Clinical trial NCT01924169 · TERMINATED
Trial details
- NCT number
- NCT01924169
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-24
- Primary completion
- 2017-02-21
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.